Friedland; Ari E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Friedland; Ari E..The latest application filed is for "crispr-cas-related methods, compositions and components for cancer immunotherapy".

Company Profile

6.8.16

Friedland; Ari E. - Boston MA
Friedland; Ari E. - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CRISPR/cas-related methods and compositions for treating herpes simplex virus Grant 11,390,861 - Friedland , et al. July 19, 2	2022-07-19
Crispr-cas-related Methods, Compositions And Components For Cancer Immunotherapy App 20220106600 - Welstead; G. Grant ; et al.	2022-04-07
CRISPR/CAS-related methods and compositions for treating sickle cell disease Grant 11,242,525 - Friedland , et al. February 8, 2	2022-02-08
SYSTEMS AND METHODS FOR ONE-SHOT GUIDE RNA (ogRNA) TARGETING OF ENDOGENOUS AND SOURCE DNA App 20220017927 - Friedland; Ari E. ; et al.	2022-01-20
Crispr/cas-related Methods And Compositions For Treating Herpes Simplex Virus App 20220010313 - Friedland; Ari E. ; et al.	2022-01-13
Crispr/cas-related Methods And Compositions For Treating Cystic Fibrosis App 20210380987 - Reyon; Deepak ; et al.	2021-12-09
CRISPR/CAS-related methods and compositions for treating cystic fibrosis Grant 11,028,394 - Reyon , et al. June 8, 2	2021-06-08
Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA Grant 11,028,411 - Friedland , et al. June 8, 2	2021-06-08
CRISPR/Cas-related methods and compositions for treating herpes simplex virus Grant 11,001,844 - Friedland , et al. May 11, 2	2021-05-11
SYSTEMS AND METHODS FOR ONE-SHOT GUIDE RNA (ogRNA) TARGETING OF ENDOGENOUS AND SOURCE DNA App 20200056208 - Friedland; Ari E. ; et al.	2020-02-20
Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA Grant 10,494,649 - Friedland , et al. De	2019-12-03
Crispr/cas-related Methods And Compositions For Treating Herpes Simplex Virus App 20190249157 - Friedland; Ari E. ; et al.	2019-08-15
Genetically Engineered Cells And Methods Of Making The Same App 20190136230 - SATHER; Blythe ; et al.	2019-05-09
SYSTEMS AND METHODS FOR ONE-SHOT GUIDE RNA (ogRNA) TARGETING OF ENDOGENOUS AND SOURCE DNA App 20180251792 - Friedland; Ari E. ; et al.	2018-09-06
Crispr/cas-related Methods And Compositions For Treating Herpes Simplex Virus App 20180251770 - Friedland; Ari E. ; et al.	2018-09-06
Crispr/cas-related Methods And Compositions For Treating Hepatitis B Virus App 20180236103 - Friedland; Ari E. ; et al.	2018-08-23
SYSTEMS AND METHODS FOR ONE-SHOT GUIDE RNA (ogRNA) TARGETING OF ENDOGENOUS AND SOURCE DNA App 20180201956 - Friedland; Ari E. ; et al.	2018-07-19
Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA Grant 10,006,054 - Friedland , et al. June 26, 2	2018-06-26
Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA Grant 9,963,719 - Friedland , et al. May 8, 2	2018-05-08
Crispr/cas-related Methods And Compositions For Treating Sickle Cell Disease App 20170314015 - FRIEDLAND; Ari E. ; et al.	2017-11-02
Crispr-cas-related Methods, Compositions And Components For Cancer Immunotherapy App 20170175128 - WELSTEAD; G. Grant ; et al.	2017-06-22
Crispr/cas-related Methods And Compositions For Treating Herpes Simplex Virus Type 1 (hsv-1) App 20170073685 - Maeder; Morgan L. ; et al.	2017-03-16
Crispr/cas-related Methods And Compositions For Treating Cystic Fibrosis App 20170022507 - Reyon; Deepak ; et al.	2017-01-26
Crispr/cas-related Methods And Compositions For Treating Hiv Infection And Aids App 20170007679 - Maeder; Morgan L. ; et al.	2017-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.